NewAmsterdam Pharma Company N.V. NAMS
19.90 USD +0.16 (+0.81%)
As ofNov 19, 2026, 9:45 AM EST
19.73 Day range 20.36
17.90 52-week range 42.21
- YTD
- -43.27%
- 1 year
- -48.47%
News
benzinga.com Cantor Fitzgerald Maintains Overweight on NewAmsterdam Pharma Co, Raises Price Target to $61 Cantor Fitzgerald analyst Steve Seedhouse maintains NewAmsterdam Pharma Co (NASDAQ:NAMS) with a Overweight and raises the price target from $52 to $61.
benzinga.com Needham Maintains Buy on NewAmsterdam Pharma Co, Lowers Price Target to $46 Needham analyst Serge Belanger maintains NewAmsterdam Pharma Co (NASDAQ:NAMS) with a Buy and lowers the price target from $48 to $46.
benzinga.com NewAmsterdam Pharma Q3 EPS $(0.14) Beats $(0.51) Estimate, Sales $19.164M Beat $7.340M Estimate NewAmsterdam Pharma (NASDAQ:NAMS) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.51) by 72 percent. This is a 77.05 percent increase over losses of…
